cagrilintide with retatrutide dosage peptide vs vs tirzepatide vs. Tirzepatide: The New Contender vs. the Current Leader 🧬 Spotlight: Tirzepatide vs. – cagrilintide retatrutide Once-weekly – cagrilintide dosage with retatrutide -

Side effect rates at 12mg are meaningfully higher than at 8mg: Nausea: 43.2% of participants (vs 38.1% at 9mg) Diarrhea: 33.1% (vs 34.7% at 9mg) Constipation: 25.0% (vs 21.8% at 9mg) Vomiting: 20.9% (vs 20.4% at 9mg) The decision between 8mg, 10mg, and 12mg as a maintenance dose should be made based on individual response

Get great features with your free account Create your free account

Growth hormone secretagogues (GHSs) and GHRH analogues Agents such as GHRH analogues and ghrelin receptor agonists (e.g., tesamorelin, macimorelin, ipamorelin and related molecules) stimulate endogenous GH release rather than providing recombinant GH itself

Presented for research literature review only Bohan TP et al

Differential Effect of Serotonin on Cytokine Production in Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells: Involvement of 5-hydroxytryptamine2A Receptors